Anpocogin

阿珀可近

Report date: 2024/02/02 17:15:56

Base Information

Drug NameAnpocogin
Drug Alias NameNAPc2rNAPc2Nematode Anticoagulant Protein c2Recombinant Nematode Anticoagulant c2Recombinant NAPc2 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitorsTissue factor inhibitors
TargetsAngiopoietin-1Tissue factor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesArgentinaBrazil
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDendreon Uk Ltd
China Registration ClassN/A

Develop Information

Active CompaniesArca Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A